GPR105-Targeted Therapy Promotes Gout Resolution as a Switch Between NETosis and Apoptosis of Neutrophils

GPR105-Targeted Therapy Promotes Gout Resolution as a Switch Between NETosis and Apoptosis of Neutrophils

Authors: Chunxiao Liu, Mengze Zhou, Wenjiao Jiang, Shumin Ye, Sheng Tian, Cheng Jiang, Kun Hao, Huanqiu Li, Qinghua Hu

Citation: Liu C, Zhou M, Jiang W, Ye S, Tian S, Jiang C, Hao K, Li H, Hu Q. GPR105-Targeted Therapy Promotes Gout Resolution as a Switch Between NETosis and Apoptosis of Neutrophils. Front Immunol. 2022 Mar 30;13:870183. doi: 10.3389/fimmu.2022.870183. PMID: 35432308; PMCID: PMC9005804.

Used in this study: Heterozygous genotype GPR105+/− Sprague Dawley (SD) rat

Read entire article

Share:

Back to top